Sophia Wu - Jul 1, 2021 Form 4/A - Amendment Insider Report for AvePoint, Inc. (AVPT)

Role
Chief Financial Officer
Signature
/s/ Brian Leaf, Attorney-in-fact
Stock symbol
AVPT
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/2/2021, 04:05 PM
Date Of Original Report
Jul 6, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVPT Common Stock Award $0 +168K $0.00 168K Jul 1, 2021 By Spouse F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVPT Stock Option (right to buy) Award $0 +38K $0.00 38K Jul 1, 2021 Common Stock 38K $1.59 Direct F4
transaction AVPT Stock Option (right to buy) Award $0 +28.5K $0.00 28.5K Jul 1, 2021 Common Stock 28.5K $1.59 Direct F5
transaction AVPT Stock Option (right to buy) Award $0 +217K $0.00 217K Jul 1, 2021 Common Stock 217K $3.90 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received on July 1, 2021 pursuant to that certain Business Combination Agreement and Plan of Reorganization ("BCA"), dated as of November 23, 2020, as amended on December 30, 2020, March 8, 2021 and May 18, 2021, by and among Apex Technology Acquisition Corporation ("Apex"), Athena Technology Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Apex, Athena Technology Merger Sub 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Apex and AvePoint, Inc. a Delaware corporation ("Former AvePoint") in exchange for Former AvePoint shares.
F2 The BCA provides that the former stockholders of Former AvePoint will receive additional shares of the Issuer's Common Stock if the Issuer's closing share price equals or exceeds $12.50, $15.00 and $17.50 for any 20 trading days within any consecutive 30-trading day period prior to July 1, 2028. The Reporting Person's right to receive additional shares pursuant to this earn-out became fixed and irrevocable on July 1, 2021, the effective date of the merger.
F3 These shares are held by the Reporting Person' spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by her spouse and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 25% of the shares underlying this option vested on September 3, 2019 and the remaining 75% of the shares underlying this option have vested or will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.
F5 25% of the shares underlying this option vested on January 10, 2020 and the remaining 75% of the shares underlying this option have vested or will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.
F6 25% of the shares underlying this option vest on August 12, 2021 and the remaining 75% of the shares underlying this option will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.